Nevro Stimulator Lawsuit MDL Request Opposed by Manufacturer

Nevro Corporation is resisting consolidation of multiple spinal cord stimulator lawsuits into a federal MDL, claiming that centralized litigation would not improve efficiency. The company's opposition comes as plaintiffs nationwide pursue claims alleging that Nevro's devices malfunctioned, migrated, or caused nerve damage requiring revision or removal surgery.

The lawsuits involve allegations that Nevro failed to adequately test the devices or warn patients and medical personnel about potential health risks and failure rates. Additional claims assert that the manufacturer allowed unlicensed sales representatives to program the devices, sometimes resulting in severe pain for patients. Spinal cord stimulators are designed to treat chronic pain by using electrical pulses to interrupt pain signals before they reach the brain through implanted electrodes and a battery-powered pulse generator.

Nevro is among several medical device manufacturers currently facing a surge in spinal cord stimulator litigation. The company's MDL opposition brief indicates that multiple plaintiffs' counsel view consolidation as beneficial to case management and resolution, while the defendant argues against the efficiency gains typically associated with centralized proceedings.

This is a curated brief from the PlaintiffWire news desk. Read the original report at AboutLawsuits.